about
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinolEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.The crystal structure of a novel mammalian lectin, Ym1, suggests a saccharide binding siteSevere Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationHuman leukocyte antigens and drug hypersensitivityENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunitA macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin.Methotrexate-induced epidermal necrosis: A case series of 24 patients.HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p.Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury.Clinical and Genetic Factors Associated With Thiazide-Induced Hyponatremia.Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection.Genetic predisposition of life-threatening antiepileptic-induced skin reactions.Pharmacogenetics of toxic epidermal necrolysis.Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.An IL-7 splicing-defect lymphopenia mouse model revealed by genome-wide mutagenesis.Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.Digging up the human genome: current progress in deciphering adverse drug reactions.Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions.Mapping of psoriasis to 17q terminus.Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.Indigenous leishmaniasis in Taiwan: report of a case.HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.Genetic predictors of thiazide-induced serum potassium changes in nondiabetic hypertensive patients.Genetic variation in C-reactive protein in ethnic Chinese population in Taiwan.Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation.The function of HLA-B*13:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions.Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
P50
Q24555784-71B907A4-DFDF-4FB1-AC45-A46FF8996430Q26800980-A36E8193-A71E-40B3-A082-DED7E861D6E6Q27630895-17029C72-9324-44C2-8C57-8C6E0C937D49Q28076600-E0C1E39D-4A65-4292-A2A6-DD05CB4B7ABEQ28235855-CE2DE9CD-1343-4112-B700-E3FE63690023Q28586801-F43920C9-B208-4DF4-9EA9-678FF3828A9AQ30663914-253389FB-CE62-43FC-9CFE-758032B9F657Q33441811-0D86550B-0EF3-4549-B194-725465DFA100Q34005708-7189B33D-83CC-404F-9C46-5EA3D040940CQ34502241-3AA4C4AE-7547-4CB8-888F-F446278D591EQ34856932-77B5C6A9-5754-4D61-9163-CF95D78DCD7DQ35130996-710602BA-F949-4755-95F2-A7E56D842BC4Q36153141-6D7846EA-8EA3-4E83-9C27-215D27E813E2Q36374463-A6E82CD1-490B-47B6-8CF4-AD8C85C9C4C9Q37650570-C70CD3A3-C01B-44C0-A864-3269711A7E45Q37763930-BADFCE8F-C20D-4142-BC7B-30DA5C61DA66Q37801798-439EE898-3D7D-4779-AC2A-8A20605C1EABQ38708244-11EA03F2-15AE-4545-A44F-9BE551DECB4CQ38997748-B354062D-25EA-4265-9E8C-9A68E9F65EF2Q39068061-4F92122D-6959-45C1-97FB-056F444B862EQ39398884-A98D037A-631F-427D-8D22-2E21F4549D54Q40199586-45B02947-90BC-4532-B97D-6BE62F08A2D4Q40716644-A83AA6BD-CDFA-40C2-8411-6A1CEE11FD0CQ40969931-7FB8911F-4149-4A4C-B099-BF6EF12C04AAQ41889353-062330C0-AA05-4FCE-BC59-2314CCC898ADQ42252963-5ED1A25B-B9FB-439D-B273-460D76835AD0Q43073355-812F5AFA-057F-4124-B13A-2BF510F88938Q44238856-42CF00CD-0EC9-43FD-811C-742C75E64A0DQ44949302-11AF72F5-E7D6-427A-80B0-76B7203CEA78Q45198114-DB162A78-3C54-4F54-919B-2A20CFEF47F2Q46483569-39A446DE-F2A2-4364-9C52-BF72CCB4D737Q46774549-D406AEBA-5456-4E06-A4E2-476F15BA1FD0Q46824553-8B146F01-ED48-4C28-95BA-B82CD3400C5CQ46859144-32DC888C-BE0D-48A8-9316-9102397798ECQ48320989-6CEE3262-DC42-4FED-9EEA-9ABA28469195Q48497713-9B584F1D-41F1-471E-91E7-1D30767EAFB1Q48558552-9D4E5976-8F48-4B35-9B7E-F79234472F31Q49847278-7DA4298D-1AD2-444C-BC80-963BF6AFE5C4Q50063459-13042B61-B30C-442E-A53E-D468482B328FQ50115047-2A840539-64F5-4FC2-978A-1EC2AC5B2730
P50
description
researcher
@en
wetenschapper
@nl
name
S I Hung
@en
S I Hung
@nl
type
label
S I Hung
@en
S I Hung
@nl
prefLabel
S I Hung
@en
S I Hung
@nl
P106
P31
P496
0000-0001-6531-5538